IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response
Interleukin-1 receptor antagonist (IL1RA) is an anti-inflammatory and anti-tumor protein, and a member of the Interleukin-1 (IL-1) family. Our previous finding showed that IL1RA is a tumor marker for oral squamous cell carcinoma (OSCC), but the exact mechanism is unknown. The present study aims to i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325001597 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849691786364059648 |
|---|---|
| author | Yujie Ding Yufei Shan Jiaqi Gu Jie Yi Zhida Sun |
| author_facet | Yujie Ding Yufei Shan Jiaqi Gu Jie Yi Zhida Sun |
| author_sort | Yujie Ding |
| collection | DOAJ |
| description | Interleukin-1 receptor antagonist (IL1RA) is an anti-inflammatory and anti-tumor protein, and a member of the Interleukin-1 (IL-1) family. Our previous finding showed that IL1RA is a tumor marker for oral squamous cell carcinoma (OSCC), but the exact mechanism is unknown. The present study aims to investigate the biological role of IL1RA in the progression of OSCC in vitro and in vivo and the underlying molecular mechanism. IL1RA was lowly expressed in OSCC specimens and cells, and its overexpression significantly inhibited the proliferation and migration of OSCC cell lines CAL27 and HN6. In nude mice bearing OSCC xenografts, in vivo overexpression of IL1RA significantly reduced tumor growth without influencing epithelial-mesenchymal transition (EMT). Differentially expressed genes (DEGs) in OSCC cells overexpressing IL1RA were identified by RNA sequencing (RNA-seq), and they were significantly enriched in cancer-associated signaling pathways like type I interferon response. IL1RA upregulated interferon alpha (IFNA) and interferon beta (IFNB), known for their anti-cancer properties, in OSCC cells and specimens. In conclusion, IL1RA inhibits the malignant progression of OSCC by mediating the type I interferon response. |
| format | Article |
| id | doaj-art-e5be1128d2a44a95b96557e7593764bf |
| institution | DOAJ |
| issn | 1936-5233 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Translational Oncology |
| spelling | doaj-art-e5be1128d2a44a95b96557e7593764bf2025-08-20T03:20:55ZengElsevierTranslational Oncology1936-52332025-08-015810242810.1016/j.tranon.2025.102428IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon responseYujie Ding0Yufei Shan1Jiaqi Gu2Jie Yi3Zhida Sun4Department of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing, Jiangsu, China; Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, Jiangsu, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing, Jiangsu, China; Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, Jiangsu, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing, Jiangsu, China; Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, Jiangsu, ChinaYancheng Stomatological Hospital, Yancheng, Jiangsu, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing, Jiangsu, China; Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, Jiangsu, China; Corresponding author at: Department of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, 136 Hanzhong Road, Nanjing, Jiangsu 210029, China.Interleukin-1 receptor antagonist (IL1RA) is an anti-inflammatory and anti-tumor protein, and a member of the Interleukin-1 (IL-1) family. Our previous finding showed that IL1RA is a tumor marker for oral squamous cell carcinoma (OSCC), but the exact mechanism is unknown. The present study aims to investigate the biological role of IL1RA in the progression of OSCC in vitro and in vivo and the underlying molecular mechanism. IL1RA was lowly expressed in OSCC specimens and cells, and its overexpression significantly inhibited the proliferation and migration of OSCC cell lines CAL27 and HN6. In nude mice bearing OSCC xenografts, in vivo overexpression of IL1RA significantly reduced tumor growth without influencing epithelial-mesenchymal transition (EMT). Differentially expressed genes (DEGs) in OSCC cells overexpressing IL1RA were identified by RNA sequencing (RNA-seq), and they were significantly enriched in cancer-associated signaling pathways like type I interferon response. IL1RA upregulated interferon alpha (IFNA) and interferon beta (IFNB), known for their anti-cancer properties, in OSCC cells and specimens. In conclusion, IL1RA inhibits the malignant progression of OSCC by mediating the type I interferon response.http://www.sciencedirect.com/science/article/pii/S1936523325001597Oral squamous cell carcinomaInterleukin-1 receptor antagonistType I interferon responseInterferon αInterferon β |
| spellingShingle | Yujie Ding Yufei Shan Jiaqi Gu Jie Yi Zhida Sun IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response Translational Oncology Oral squamous cell carcinoma Interleukin-1 receptor antagonist Type I interferon response Interferon α Interferon β |
| title | IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response |
| title_full | IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response |
| title_fullStr | IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response |
| title_full_unstemmed | IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response |
| title_short | IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response |
| title_sort | il1ra inhibits the progression of oral squamous cell carcinoma by mediating type i interferon response |
| topic | Oral squamous cell carcinoma Interleukin-1 receptor antagonist Type I interferon response Interferon α Interferon β |
| url | http://www.sciencedirect.com/science/article/pii/S1936523325001597 |
| work_keys_str_mv | AT yujieding il1rainhibitstheprogressionoforalsquamouscellcarcinomabymediatingtypeiinterferonresponse AT yufeishan il1rainhibitstheprogressionoforalsquamouscellcarcinomabymediatingtypeiinterferonresponse AT jiaqigu il1rainhibitstheprogressionoforalsquamouscellcarcinomabymediatingtypeiinterferonresponse AT jieyi il1rainhibitstheprogressionoforalsquamouscellcarcinomabymediatingtypeiinterferonresponse AT zhidasun il1rainhibitstheprogressionoforalsquamouscellcarcinomabymediatingtypeiinterferonresponse |